Mr Denzil Benjamin, ICON: New guidelines by India's CDSCO will re-define the industry in 2013

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

Adapting technology and tools to address the issues of increasing research and development (R&D) costs, slow results, lack of funding, regulatory requirements, multiple databases, and s...Read more

India strengthens clinical trial regulations

Clinical Research |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian government has announced several measures. Union Minister for Health and Family Welfare Mr...Read more

PAREXEL inks services deal with Taiwan hospital

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

Singapore: Taiwan's PAREXEL International, a biopharmaceutical services provider, and National Taiwan University Hospital (NTUH) have collaborated to provide drug development services in Ta...Read more

Merger and Acquisition in CRO-Annual BSA CRO Survey

Clinical Research |  Analysis | By Nandita Singh | 0 Comment | 11 Oct, 2015

According to business intelligence provider, GBI Research, total number of deals in the global contract research organization market reached 700 between January 2010 and April 2015, achievi...Read more

Fight between local and global CROs intensifies

Clinical Research |  Influencers | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2012

Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special responsibility for the growth and development in Asia Pacific (APA C)....Read more

Malaysia to build on its clinical research potential

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

Malaysia's aspiration is to be a developed nation by the year 2020. With 10 years more to prepare for this anticipated year, current Prime Minister Datuk Seri Mohd Najib Tun Razak announc...Read more

PPD acquires patient recruitment firm Acurian

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

Singapore: Pharmaceutical Product Development, (PPD) has acquired Acurian, a service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. "A...Read more

Daiichi Sankyo extends Medidata Clinical Cloud use to China

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical trials conducted by its division in China. Daiichi Sankyo will bring ...Read more

CROs and BPOs give pharmacovigilance a new edge

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

Demand in emerging markets is opening up newer opportunities across various sectors and life sciences companies have several compelling reasons to build their presence in these markets. Em...Read more

China: Emerging drug discovery destination

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Apr, 2012

China's growing economic strength and population of 1.3 billion people holds tremendous potential for global pharma and biotech companies as a location for clinical trials, as well as a mar...Read more

Linear Clinical Research wins Emerging Exporter Award

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annual Premier's Western Australian Export Awards. The awards aim to recog...Read more

India's CRO industry raises concerns at workshop

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

New Delhi: At a media workshop on the clinical research industry (CRO) held at Delhi on July 13, 2012, industry experts urged the media to report in a balanced way. The workshop attended by...Read more

Senz starts phase II cancer trial

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2012

Singapore: Senz Oncology announced that the first patient has commenced treatment in a phase I/II clinical evaluation of VAL-1000 in patients with acute leukaemias (protocol SO-2012-1)...Read more

India suffers adverse effects of clinical research

Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the largest democracy of the world, which boasts of a population of 1.27...Read more

Resverlogix initiates phase II diabetes trials

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2012

Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabo...Read more

Marken gets 12-year license in China

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: Global clinical supply chain solutions provider Marken has been granted a 12-year license to ship biological samples and drug product within China. Marken plans to continue its e...Read more

Which domain of clinical research do APAC CROs focus on?

Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Good Clinical Practice-certified investigators ensure quality in Malaysia

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

The clinical trials landscape in Malaysia is very easy to navigate. The Malaysian government has been actively promoting clinical trials and other facets of biomedical development for man...Read more